1. Home
  2. MMYT vs PCVX Comparison

MMYT vs PCVX Comparison

Compare MMYT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

HOLD

Current Price

$85.99

Market Cap

7.0B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$43.72

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMYT
PCVX
Founded
2000
2013
Country
India
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.0B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
MMYT
PCVX
Price
$85.99
$43.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$120.00
$101.67
AVG Volume (30 Days)
980.0K
1.5M
Earning Date
01-22-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$1,011,011,000.00
N/A
Revenue This Year
$19.90
N/A
Revenue Next Year
$19.52
N/A
P/E Ratio
$119.99
N/A
Revenue Growth
14.55
N/A
52 Week Low
$69.69
$27.66
52 Week High
$122.35
$93.77

Technical Indicators

Market Signals
Indicator
MMYT
PCVX
Relative Strength Index (RSI) 66.75 43.97
Support Level $69.69 $43.34
Resistance Level $75.72 $45.15
Average True Range (ATR) 2.94 1.89
MACD 2.03 -0.59
Stochastic Oscillator 94.86 15.32

Price Performance

Historical Comparison
MMYT
PCVX

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: